Interpace Biosciences, Inc.
IDXG
$1.98
-$0.01-0.50%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 24.58M | 3.80M | 4.56M | 7.64M | 6.70M |
| Total Depreciation and Amortization | 821.00K | 811.00K | 789.00K | 778.00K | 748.00K |
| Total Amortization of Deferred Charges | 58.00K | 42.00K | 26.00K | 11.00K | -- |
| Total Other Non-Cash Items | -20.91M | 565.00K | 947.00K | 740.00K | 872.00K |
| Change in Net Operating Assets | 1.29M | -340.00K | -1.27M | -3.23M | -3.68M |
| Cash from Operations | 5.83M | 4.88M | 5.06M | 5.94M | 4.65M |
| Capital Expenditure | -356.00K | -447.00K | -852.00K | -848.00K | -876.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -356.00K | -447.00K | -852.00K | -848.00K | -876.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -4.40M | -4.90M | -5.50M | -6.50M | -5.60M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -18.00K | -46.00K | -46.00K | -46.00K | -46.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -13.00K | -174.00K | -174.00K | -161.00K | -161.00K |
| Cash from Financing | -4.43M | -5.12M | -5.72M | -6.71M | -5.81M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.04M | -690.00K | -1.52M | -1.62M | -2.04M |